October 2013

Article
Updated
Article URC Participates in the 44th World Conference on Lung Health

URC will again have a significant presence at this year’s Union World Conference on Lung Health from October 30–November 3 in Paris, France. In many of the 22 countries that account for more than 80% of TB cases worldwide, we are supporting national TB programs through innovative approaches to address systemic barriers to effective prevention and treatment. The conference provides an opportunity to share our TB work with thousands of health care professionals, researchers, and advocates.

Below is a list of our activities. We look forward to seeing you there or interacting with you on Twitter @urcchs using #LungHealth

- See more at: http://www.urc-chs.com/recent/news?newsItemID=374#sthash.9tWg43fj.dpuf

URC will again have a significant presence at this year’s Union World Conference on Lung Health from October 30–November 3 in Paris, France. In many of the 22 countries that account for more than 80% of TB cases worldwide, we are supporting national TB programs through innovative approaches to address systemic barriers to effective prevention and treatment. The conference provides an opportunity to share our TB work with thousands of health care professionals, researchers, and advocates.

Information and resources from URC’s TB projects in South Africa, Swaziland, Georgia, Malawi, Bangladesh, Vietnam, Indonesia and Cambodia will be on display, along with URC’s global TB CARE II project at the URC booth. 

Please see attached newsletter or visit the URC web page at http://www.urc-chs.com/recent/news?newsItemID=374 for more information.

 

30 Oct 2013 10:54
Article TB CARE II Bangladesh: Infographic

Bangladesh is a low income country with the population of 150.5 million. TB remains a major public health problem in Bangladesh: the country is among both high TB and high MDR-TB burden countries. More than 170,000 cases of TB including 106,790 smear positives were notified in 2012. Approximately, 70,000 people die from TB every year. The estimated MDR-TB burden is 1.4% among the new and 29% among the retreatment cases. (WHO World TB report 2013).

26 Jul 2016 15:29
Article TB CARE II Bangladesh: Changing Lives of MDR TB Patients
Improving management of Multi-Drug-resistant TB (MDR TB) is a special focus of the TB CARE II project. It is estimated that there are 3,800 MDR TB cases annually in Bangladesh. A large proportion of these cases remain undetected and untreated, potentially increasing the risk of infection in the community.
 
It is not possible to combat the threat of MDR TB without a synchronized effort to expand national capacity both for diagnosis and treatment. To this end, the TB CARE II project started two new interventions in 2012. The introduction of Gene Xpert technology has been helping a large number of suspected patients with correct and faster diagnosis of drug resistant TB. The community based approach for management has significantly reduced treatment delays by shortening hospital stays and allowing the patients extended time at home to complete their treatment.
 
These efforts resulted in a substantial increase in the enrolment of MDR TB patients in treatment in less than two years.
This booklet titled ‘Changing Lives of MDR TB Patients’ has been prepared to highlight the impact of MDR TB on patients and their families and to demonstrate the acievements that have been made in improving systems of care. The stories epitomize the trials and tribulations that transpire in the lives of MDR TB patients. We hope these stories will generate awareness about MDR TB and inspire readers to join our fight against TB.
 
08 Oct 2013 09:07